Contemporary evaluation of the causes of cardiac tamponade: Acute and long-term outcomes

Abstract

Results: Cardiac tamponade was observed in 83 patients (52% females). Major etiologies included complications of percutaneous cardiac interventions (36%) and malignancies (primarily lung cancer; 23%), infectious/inflammatory causes (15%) and mechanical complications of myocardial infarction (12%). Sixteen (19%) patients died during the index hospitalization. Acute presentation of symptoms and lower quantity of effusion were associated with in-hospital mortality (p = 0.045 and p = 0.007). Tamponade secondary to malignancy was associated with the most substantial increment in post-discharge mortality (from 16% in-hospital to 68% 1-year mortality). During the mean follow-up of 45 months, 39 (45%) patients died. Malignancies, mechanical complications of myocardial infarction and bleeding/coagulation abnormalities were etiologies associated with poor survival (80% mortality during follow-up). Tamponade secondary to complications of percutaneous cardiac interventions or infectious/inflammatory causes were associated with significantly lower mortality (28% and 17%; log rank p < 0.001 (Cardiol J 2016; 23, 1: 57-63)

Ultrasound-assisted diagnosis of intraoperative cardiac tamponade during hemihepatectomy: a case report

“…3 However, a recent study showed that iatrogenic complications were the most prevalent etiology for cardiac tamponade (36%). 4 Presentation may be rapid after chest wall trauma, aortic or cardiac rupture, or as a complication of cardiac procedures, necessitating prompt diagnosis and treatment. 4 Most reported cases of iatrogenic cardiac tamponade resulted from interventional procedures (e.g., percutaneous coronary intervention, transcatheter aortic valve implantation, pacemaker/implantable cardioverter-defibrillator implantation, arrhythmia ablation, and endomyocardial biopsy).…”

“…4 Presentation may be rapid after chest wall trauma, aortic or cardiac rupture, or as a complication of cardiac procedures, necessitating prompt diagnosis and treatment. 4 Most reported cases of iatrogenic cardiac tamponade resulted from interventional procedures (e.g., percutaneous coronary intervention, transcatheter aortic valve implantation, pacemaker/implantable cardioverter-defibrillator implantation, arrhythmia ablation, and endomyocardial biopsy). 5,6 To the best of our knowledge, we report the first case of intraoperative cardiac tamponade during hemihepatectomy.…”

A cardiogen sokk modellezése pericardialis tamponáddal

“…Cardiogen sokk általában myocardialis infarctus után alakul ki, emellett szívsebészeti beavatkozásokat követően, valamint számos sürgősségi sebészi kórkép (például hasi aortaaneurysma-ruptura), úgynevezett nem szívsebészeti invazív beavatkozások (non-cardiac surgical procedures -NCSP), szeptikus, vérzéses sokk után, intra-vagy poszt operatív szövődményeként is jelentkezik. 1 Cardiogen sokkot okozhat a szívsebészeti és invazív kardiológiai beavatkozások egyik legveszélyesebb szövődménye, a pericardialis tamponád is. A tamponád során a szívburokban leggyakrabban folyadék gyülemlik fel, amely lehet transsudatum vagy genny, de a klinikai gyakorlatban főleg a szívburokba történő vérzés okozhatja.…”

Prevalence, management and outcomes of cardiac tamponade complicating 66,812 invasive cardiac procedures: single-center clinical registry

“…In recent years, the application of invasive cardiovascular procedures and the use of antiplatelet and anticoagulation drugs have increased in clinical medicine [ 1 ]. The risk of iatrogenic cardiac tamponade (CT) or pericardial effusion increases with the need for transseptal puncture and intraprocedural anticoagulation [ 2 ].…”